We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

114 hedge funds and large institutions have $701M invested in NxStage Medical Inc. in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,689% more call options, than puts

Call options by funds: $2.18M | Put options by funds: $28K

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

30% more capital invested

Capital invested by funds: $541M → $701M (+$161M)

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

0% more funds holding

Funds holding: 114 → 114 (0)

30% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 44

Holders
114
Holders Change
–
Holders Change %
0%
% of All Funds
3.29%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
21
Increased
31
Reduced
44
Closed
19
Calls
$2.18M
Puts
$28K
Net Calls
+$2.15M
Net Calls Change
+$1.91M

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$56M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$17M
3
APG Asset Management
APG Asset Management
Netherlands
+$15.8M
4
CII
CR Intrinsic Investors
Connecticut
+$10.4M
5
RG
Redmile Group
California
+$5.21M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$23.1M
2
WI
WHV Investments
California
-$21.4M
3
Norges Bank
Norges Bank
Norway
-$13.6M
4
Wells Fargo
Wells Fargo
California
-$8.8M
5
CS
Credit Suisse
Switzerland
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$453K – – –
Nomura Holdings
77
Nomura Holdings
Japan
$423K +$428K +32,844 New
AQR Capital Management
78
AQR Capital Management
Connecticut
$363K +$372K +28,500 New
US Bancorp
79
US Bancorp
Minnesota
$347K +$158K +12,137 +80%
PPA
80
Parametric Portfolio Associates
Washington
$324K +$8.15K +625 +3%
UBS AM
81
UBS AM
Illinois
$261K – – –
GPGA
82
Grandeur Peak Global Advisors
Utah
$255K +$187K +14,300 +251%
Barclays
83
Barclays
United Kingdom
$248K +$151K +11,603 +128%
KIA
84
Kopp Investment Advisors
Minnesota
$247K +$109K +8,330 +76%
QIM
85
Quantitative Investment Management
Virginia
$247K +$253K +19,400 New
HI
86
HBK Investments
Texas
$234K -$498K -38,200 -67%
Credit Agricole
87
Credit Agricole
France
$217K -$599K -45,955 -73%
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
$210K -$19.9K -1,524 -8%
Principal Financial Group
89
Principal Financial Group
Iowa
$209K -$172K -13,171 -45%
Invesco
90
Invesco
Georgia
$207K +$195K +14,920 +1,143%
Goldman Sachs
91
Goldman Sachs
New York
$201K +$206K +15,759 New
U
92
UBS
Switzerland
$190K -$79.4K -6,087 -29%
New York State Common Retirement Fund
93
New York State Common Retirement Fund
New York
$185K -$196K -15,000 -51%
TMC
94
Trellus Management Company
Florida
$167K -$32.6K -2,500 -16%
AL
95
Airain Ltd
Guernsey
$151K +$155K +11,846 New
JMPWA
96
JP Morgan Private Wealth Advisors
California
$137K +$140K +10,720 New
MC
97
Moors & Cabot
Massachusetts
$137K +$140K +10,750 New
Morgan Stanley
98
Morgan Stanley
New York
$131K -$360K -27,628 -73%
Citigroup
99
Citigroup
New York
$128K -$161K -12,366 -55%
NIM
100
Needham Investment Management
New York
$127K -$1.43M -110,000 -92%
2 3
4
5 6

NXTM Hedge Fund Activity: Q1 2014 in Review

114 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2014, worth a combined $701M — up 30% from $541M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NXTM positions and 19 closed out — a net gain of 2 holders — while 31 added to existing stakes and 44 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $56M. The largest seller was Deerfield Management, cutting an estimated $23.1M.

  • 114 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $701M of NxStage Medical Inc. stock for Q1 2014, up 30% quarter-over-quarter.
  • 21 funds opened new NxStage Medical Inc. positions in Q1 2014 and 19 closed out, a net change of +2 holders.
  • The largest NxStage Medical Inc. buyer in Q1 2014 was Gilder Gagnon Howe & Co, an estimated $56M added.
  • The largest NxStage Medical Inc. seller in Q1 2014 was Deerfield Management, an estimated $23.1M sold.

Based on aggregated 13F filings for Q1 2014.